A pilot study of telitacicept in predominantly immune-mediated necrotizing myopathy, retrospective analysis of a monocentric Chinese cohort
{{output}}
Background: Idiopathic inflammatory myopathies (IIM) are a group of rare autoimmune disorders mainly involving skeletal muscles. Telitacicept is a BAFF/APRIL inhibitor, which has a promising application in B-cell-mediated autoimm... ...
